Surgical adhesion barriers are
implants or solutions used to prevent internal scarring due to sticking of
tissues or internal organs to each other after surgery or during healing
process. Majority of adhesion barrier products are in nascent stage of product
life cycle and thus market is evolving gradually. Adhesion barrier products
considered in the report include film-based, solution-based, and gel-based
adhesion barriers.
The global Surgical
Hemostats, Internal Tissue Sealants and Adhesion Barriers Market is
estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is
expected to reach US$ 7,346.7 Mn by the end of 2027
Global Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers Market: Drivers
High number of cardiovascular
procedures is expected to propel growth of the global surgical hemostats,
internal tissue sealants and adhesion barriers market over the forecast period.
For instance, according to American Heart Association 2019 Heart Disease and
Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart
transplants were performed in the U.S. in 2014 and 2017, respectively.
Global Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers Market: Opportunities
R&D of absorbable hemostats
is expected to offer lucrative growth opportunities for players in the market.
For instance, in October 2019, researchers from Institute of Pharmacology and
Toxicology, Technische Universität Dresden, Germany, reported that naturally
prefabricated marine biomaterials can aid in development of new sponge
chitin-based absorbable hemostats as alternatives to cellulose-based fabrics.
Global Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers Market: Restraints
Restricted use of synthetic
tissue sealants is expected to hinder growth of the market. Significant
restrictions and complications are associated with the use of synthetic
polymer-based tissue glues in the internal applications. For instance,
cyanoacrylate glues have adequate acceptability for most orthopedic surgical
procedures, however, are not yet cleared for use in the internal tissue
applications because of toxic effects. They additionally need sufficient
adaptability for use in numerous procedures.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3721
Key Takeaways:
Hemostat held dominant position
in the global surgical hemostats, internal tissue sealants and adhesion
barriers market in 2019, accounting for 41.1% share in terms of value, followed
by Internal Tissue Sealants, and adhesion barriers respectively. Rising volumes
of surgical procedures performed across the world coupled with increasing
number of trauma and accident injury cases is expected to foster growth of
hemostats segment. For instance, according to the Health and Social Care
Information Centre (HSCIC), surgery is one of the most important treatments
offered by NHS care in the U.K., and accounted for 4.7 million admissions
across multiple medical domains in 2013 -14.
Orthopedic Surgeries segment held
dominant position in the global surgical hemostats, internal tissue sealants
and adhesion barriers market in 2019, accounting for 27.5% share in terms of
value, followed by Cardiovascular Surgeries and Neurological Surgeries,
respectively. Highest prevalence of bone related disorders has been reported in
North America. For instance, according to the statistics by WHO, in U.S., by
the year 2040, around 78.4 million adults aged 18 years and older will have
doctor-diagnosed arthritis, compared to 54.4 million adults in 2013-2015
Hospitals segment held dominant
position in the global surgical hemostats, internal tissue sealants and
adhesion barriers market in 2019, accounting for 67.1% share in terms of value,
followed by ASCs and specialty clinics, respectively
Market Trends
Major players in the market are
focused on launching new products to expand their product portfolio. For
instance, in June 2019, Ethicon, part of the Johnson & Johnson Medical
Devices Companies, received a 510(k) clearance from the FDA for its Vistaseal
applicators, which spray a biological sealant to stem moderate bleeding during
open or laparoscopic surgical procedures.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/surgical-hemostats-internal-tissue-sealants-and-adhesion-barriers-market-3721
Major players in the market are
also focussed on adopting M&A strategies to expand their product portfolio.
For instance, in March 2018, Baxter International Inc. completed acquisition of
two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin
topical (Recombinant) is the first and only stand-alone recombinant thrombin
and PREVELEAK Surgical Sealant is used in vascular reconstruction.
Global Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers Market: Competitive Landscape
Major players operating in the
global surgical hemostats, internal tissue sealants and adhesion barriers
market include, Ethicon (Johnson & Johnson), Baxter International Inc.,
Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi,
Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and
CSL Behring.
Global Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers Market: Key Developments
December 2019: Ethicon, part of
the Johnson & Johnson Medical Devices Companies, launched VISTASEAL Fibrin
Sealant (Human) to help surgeons manage bleeding during surgery
December 2018: Baxter
International Inc. launched its disposable curved applicator that is designed
to enhance the delivery of its Floseal Hemostatic Matrix product line
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3721
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment